About 455 results

ALLMedicine™ Direct Antiglobulin Test Center

Research & Reviews  167 results

Autoimmune hemolytic anemia: causes and consequences.
Expert Review of Clinical Immunology; Fattizzo B, Barcellini W

Jun 16th, 2022 - Autoimmune hemolytic anemia (AIHA) is classified according to the direct antiglobulin test (DAT) and thermal characteristics of the autoantibody into warm and cold forms, and in primary versus secondary depending on the presence of associated cond...

Warm autoimmune haemolytic anaemia seen in association with primary sclerosing cholangi...
BMJ Case Reports; Yohannan B, Chan KH et. al.

May 24th, 2022 - Warm autoimmune haemolytic anaemia mediated by warm agglutinins is a rare and heterogeneous disease which can be idiopathic or secondary to an underlying disease. Primary sclerosing cholangitis is a chronic autoimmune cholangiopathy that is very r...

How to approach haemolysis: Haemolytic anaemia for the general physician.
Clinical Medicine (London, England); Palmer D, Seviar D

May 19th, 2022 - Haemolytic anaemia can seem like a complicated topic. The constellation of reticulocytosis, increased lactate dehydrogenase levels, increased unconjugated bilirubin levels and decreased haptoglobin levels should prompt general physicians to consid...

Autoimmune hemolytic anemia in patients with relapsed Hodgkin's lymphoma after treatmen...
https://doi.org/10.1007/s10637-022-01254-2 10.1136/jitc-2020-SITC2020.0804 10.1007/s00277-021-04690-x 10.1038/clpt.1981.154 10.3389/fimmu.2020.01088 10.1053/j.seminhematol.2015.05.001 10.1111/ejh.13187
Investigational New Drugs; Tao Y, Han J et. al.

May 4th, 2022 - In August 2021, penpulimab, an anti-programmed cell death 1 (PD-1) monoclonal antibody, was approved in China for the treatment of adult patients with relapsed or refractory classic Hodgkin's lymphoma who completed at least second-line chemotherap...

Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab.
BMJ Case Reports; Dawudi Y, Federici L et. al.

Apr 30th, 2022 - Impaired immune response with uncontrolled inflammation and various immunological disorders have been reported during SARS-CoV-2 infection. Here, we report a case of cold agglutinin disease occurring during a severe coronavirus disease 2019 (COVID...

see more →

Drugs  1 results see all →

Clinicaltrials.gov  4 results

Study on Newborn Babies With a Yellow Skin Color (Neonatal Jaundice Study)

Sep 2nd, 2020 - PROCEDURES DURING PREGNANCY During the first antenatal care visit the mother will have a gestational dating ultrasound to determine the accurate gestational age. During all antenatal care visits information about the mother will be collected as pa...

Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia

Jan 10th, 2020 - Subjects will give informed consent before any protocol specific assessments. Blood samples, physical examination, CT scan and bone marrow examination will be performed to determine baseline disease status and study eligibility. All examinations m...

POOLED Red Blood Cells Prepared From Pooling 5 Leukoreduced, Irradiated RBC Units

Dec 26th, 2019 - This research study is enrolling subjects who are receiving RBC (red blood cell) blood transfusions as part of their treatment. In this study, we are testing a new way of preparing RBC units (pooled RBC units) for transfusion compared to the stand...

Data Registry of Auto Immune Hemolytic Anemia

Jul 19th, 2019 - In autoimmune hemolytic anemia (AIHA) auto-antibodies directed against red blood cells (RBCs) lead to increased RBC clearance (hemolysis). This can result in a potentially life-threatening anemia. AIHA is a rare disease with an incidence of 1-3 pe...

see more →

News  10 results

Bullous Systemic Lupus Erythematosus Successfully Treated With Rituximab
Christopher D. Lowe, MD, Catherine A. Brahe, MD et. al.

Jun 12th, 2019 - Bullous systemic lupus erythematosus (BSLE) is a rare cutaneous presentation of systemic lupus erythematosus (SLE). 1 Although 59% to 85% of SLE patients develop skin-related symptoms, fewer than 5% of SLE patients develop BSLE.

Consider treatment, testing when CLL symptoms emerge
Sharon Worcester

Nov 13th, 2018 - CHICAGO – Asymptomatic chronic lymphocytic leukemia (CLL) patients should be observed, but consider therapy when symptoms develop, said Paul M. Barr, MD.

FDA clears new blood typing, screening instrument
Jennifer Smith

Nov 13th, 2018 - The Food and Drug Administration has granted marketing clearance for the immunohematology instrument NEO Iris. NEO Iris is a fully automated blood bank instrument designed for the mid- to high-volume laboratory, according to Immucor, the company m.

Cold hemolytic anemia: a rare complication of influenza A
Exler et al

Dec 15th, 2017 - Autoimmune hemolytic anemia (AIHA) is characterized by the temperature at which the auto-antibody has the greatest avidity for the target red cell antigen, either warm or cold forms. It is detected by a positive direct antiglobulin test (DAT) also.

I Thought a Blood Transfusion Would Make Me Feel Better

Mar 28th, 2011 - Clinical History A 60-year-old man undergoing chemotherapy for acute myelogenous leukemia was receiving a red blood cell (RBC) transfusion because his hemoglobin had dropped to 7.5 g/dL. He had received 6 units of RBCs and 3 units of platelets dur...

see more →